Press-release for stocks for tonix pharmaceuticals holding corp.

Prices are updated after-hours

conference entities : Tonix pharmaceuticals holding corp.

save search

Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference
Published: 2024-02-20 (Crawled : 13:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -58.06% | O: 2.23% H: 0.0% C: -4.1%
ceo conference pharmaceuticals

Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in January: Focus is on TNX-102 SL for the Management of Fibromyalgia Following Positive Topline Results in Second Pivotal Phase 3 Trial
Published: 2024-01-03 (Crawled : 12:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -61.71% | O: -0.69% H: 3.59% C: -5.47%
tnx-102 management fibromyalgia positive pharmaceuticals topline trial results

Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in December
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -67.28% | O: 2.25% H: 10.0% C: -2.3%
pharmaceuticals

Tonix Pharmaceuticals to Present at the 2023 ThinkEquity Conference
Published: 2023-10-12 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -72.77% | O: 1.24% H: 0.87% C: -1.65%
conference pharmaceuticals

Tonix Pharmaceuticals Provides Overview of TNX-2900 Program for the Treatment of Prader-Willi Syndrome at the Foundation for Prader-Willi Research Family Conference
Published: 2023-10-09 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -71.51% | O: -0.28% H: 4.98% C: 1.79%
tnx-2900 conference treatment pharmaceuticals research family program

Tonix Pharmaceuticals Presents New Preclinical Data at Seventh International Cancer Immunotherapy Conference 2023
Published: 2023-09-21 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -81.4% | O: -0.06% H: 0.06% C: -7.16%
conference cancer international pharmaceuticals preclinical immunotherapy

Tonix Pharmaceuticals Announces Poster Presentation Involving TNX-1700 in Preclinical Colorectal Cancer Models at the Seventh International Cancer Immunotherapy Conference 2023
Published: 2023-09-14 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -82.02% | O: 1.12% H: 2.21% C: 0.1%
tnx-1700 conference presentation cancer international pharmaceuticals preclinical immunotherapy

Tonix Pharmaceuticals Comments on Two Long COVID Conferences Sponsored by the U.S. National Academies
Published: 2023-07-06 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -90.24% | O: 1.22% H: 0.0% C: -6.63%
covid pharmaceuticals

Tonix Pharmaceuticals to Participate in the A.G.P. Virtual Healthcare Conference - May 18, 2023
Published: 2023-05-18 (Crawled : 12:00) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -91.53% | O: -0.53% H: 0.51% C: -1.06%
conference pharmaceuticals

Tonix Pharmaceuticals to Participate in the A.G.P. Virtual Healthcare Conference
Published: 2023-05-18 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -91.53% | O: -0.53% H: 0.51% C: -1.06%
conference pharmaceuticals

Tonix Pharmaceuticals to Participate in BIO CEO & Investor Conference - February 3, 2023
Published: 2023-02-03 (Crawled : 14:20) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -97.83% | O: -0.85% H: 7.69% C: 5.13%
pharmaceuticals ceo conference

Tonix Pharmaceuticals to Participate in BIO CEO & Investor Conference
Published: 2023-02-03 (Crawled : 12:20) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -97.83% | O: -0.85% H: 7.69% C: 5.13%
pharmaceuticals ceo conference

Tonix Pharmaceuticals Announces Presentation of Clinical and Non-Clinical TNX-1900 Data at the Annual Headache Cooperative of the Pacific (HCOP) Winter Conference
Published: 2023-01-31 (Crawled : 13:00) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -97.67% | O: 0.91% H: 2.7% C: 0.9%
tnx-1900 pharmaceuticals conference presentation

Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 2nd Wnt & β-catenin Targeted Drug Development Conference
Published: 2023-01-26 (Crawled : 22:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -97.77% | O: 0.0% H: 4.35% C: 0.0%
pharmaceuticals drug conference antiviral technology presentation

Tonix Pharmaceuticals to Participate in the A.G.P. Biotech Conference
Published: 2022-11-23 (Crawled : 13:00) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -93.52% | O: 3.82% H: 0.0% C: -6.32%
pharmaceuticals conference biotech

Tonix Pharmaceuticals to Present at the 2022 BioFuture Conference
Published: 2022-10-31 (Crawled : 17:00) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -94.55% | O: 1.04% H: 0.0% C: -5.05%
pharmaceuticals conference

Tonix Pharmaceuticals to Present at the 2022 ThinkEquity Conference
Published: 2022-10-19 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -94.96% | O: 0.89% H: 0.0% C: -1.68%
pharmaceuticals conference

Tonix Pharmaceuticals to Participate in the 2022 BIO-Europe Conference
Published: 2022-10-17 (Crawled : 12:20) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -94.66% | O: 2.19% H: 4.08% C: 3.57%
pharmaceuticals conference

Tonix Pharmaceuticals to Participate in the NobleCon18 Investor Conference
Published: 2022-04-12 (Crawled : 08:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -19.07% | O: -0.61% H: 0.56% C: -6.36%
conference